NCT01283984 - AZD2115 Single Ascending Dose Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Chronic Obstructive Pulmonary DiseaseLung Disease Causing Persistent Narrowing of the Airways

Interventions

DRUG

AZD2115

Single dose, oral inhalation (nebuliser solution)

DRUG

Placebo

Single dose, oral inhalation (nebuliser solution)

Trial Locations (1)

Research Site, London